Recent News
Have Anemia? A Proton Pump Inhibitor Could be to Blame.
A new study is pointing to another concerning proton pump inhibitor side effect – iron deficiency. Proton pump inhibitors – including Nexium, Prilosec, and PrevAcid — are some of the most widely-used drugs in the world. In 2013, in fact, … Continue reading
Monsanto Roundup Lawsuit Jurors Want Landmark Cancer Verdict Upheld
Jurors who recently awarded $289 million to the first plaintiff to take a Monsanto Roundup lawsuit to trial in the United States are urging a California judge to uphold their unanimous, landmark verdict. Plaintiff Dwayne Johnson, 46, a former California … Continue reading
Heart, Blood Pressure Drug Prices Soar Following Worldwide Valsartan Recall
Consumers throughout the United States are shelling out significantly more money for their heart and blood pressure drugs, thanks to a series of generic valsartan recalls that began over the summer. Valsartan Price Hikes Could Have Long-Lasting Impact According to … Continue reading
1st Ethicon Physiomesh Lawsuit Will Head to Trial in December 2019, as Federal Court Revises Bellwether Schedule
The federal court overseeing hundreds of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite Mesh implants has revised its pretrial schedule, setting the stage for the first bellwether trial to begin in December 2019. First Physiomesh Bellwether Trial to … Continue reading
Monsanto Roundup Lawsuits Move Forward, as Federal MDL Preps for First Bellwether Trial
The federal court overseeing hundreds of cancer lawsuits involving Monsanto’s Roundup weed killer will convene its first bellwether trial in February 2019. More than 560 Roundup lawsuits are currently pending in the U.S. District Court, Northern District of California, where … Continue reading
Federal Panel Denies Plaintiffs’ Motion to Centralize Gadolinium MRI Contrast Dye Lawsuits
A judicial panel has denied a plaintiffs’ motion requesting centralization of all product liability lawsuits filed against the manufacturers of linear gadolinium-based MRI contrast dyes, or GBCAs, in a single U.S. District Court. Defendants Opposed Motion to Centralize Gadolinium Toxicity … Continue reading
Chinese Drug Maker Faces Multiple Valsartan Lawsuits Following Global Recalls
The Chinese pharmaceutical manufacturer responsible for dozens of valsartan recalls around the world is now facing legal headaches in the United States. According to FiercePharma.com, Zhejiang Huahai Pharmaceutical recently disclosed that it had been named a defendant in multiple valsartan … Continue reading
European Regulator Renews Birth Defect Warning for Dolutegravir-Containing HIV Drugs
European regulators have renewed warnings for dolutegravir, an HIV medication that has been linked to neural tube birth defects when taken in the earliest days of a pregnancy. Dolutegravir and Neural Tube Birth Defects Dolutegravir is currently sold in the United States … Continue reading
